Neurogenetic laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, 15006 Prague, Czech Republic.
Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine and University Hospital, Comenius University, 85107 Bratislava, Slovakia.
Genes (Basel). 2021 May 1;12(5):684. doi: 10.3390/genes12050684.
Hearing loss is a genetically heterogeneous sensory defect, and the frequent causes are biallelic pathogenic variants in the gene. However, patients carrying only one heterozygous pathogenic (monoallelic) variant represent a long-lasting diagnostic problem. Interestingly, previous results showed that individuals with a heterozygous pathogenic variant are two times more prevalent among those with hearing loss compared to normal-hearing individuals. This excess among patients led us to hypothesize that there could be another pathogenic variant in the region/DFNB1 locus. A hitherto undiscovered variant could, in part, explain the cause of hearing loss in patients and would mean reclassifying them as patients with biallelic pathogenic variants. In order to detect an unknown causal variant, we examined 28 patients using NGS with probes that continuously cover the 0.4 Mb in the DFNB1 region. An additional 49 patients were examined by WES to uncover only carriers. We did not reveal a second pathogenic variant in the DFNB1 region. However, in 19% of the WES-examined patients, the cause of hearing loss was found to be in genes other than the . We present evidence to show that a substantial number of patients are carriers of the pathogenic variant, albeit only by chance.
听力损失是一种遗传异质性感觉缺陷,常见病因是 GJB2 基因的双等位致病性变异。然而,仅携带一个杂合致病性(单等位)变异的患者仍然存在长期的诊断问题。有趣的是,先前的结果表明,与听力正常个体相比,携带杂合致病性变异的个体在听力损失患者中更为常见,比例为两倍。这种在患者中的过度存在使我们假设在 GJB2 区域/DFNB1 基因座可能存在另一个致病性变异。一个尚未被发现的变异可以部分解释患者听力损失的原因,并将他们重新归类为 GJB2 双等位致病性变异患者。为了检测未知的因果变异,我们使用覆盖 DFNB1 区域 0.4 Mb 的连续探针对 28 名患者进行了 NGS 检测。另外 49 名患者进行了 WES 检测,以仅发现携带者。我们没有在 DFNB1 区域发现第二个致病性变异。然而,在 19%的 WES 检测患者中,听力损失的原因被发现是在 GJB2 基因以外的基因。我们提供的证据表明,大量患者是 GJB2 致病性变异的携带者,尽管只是偶然的。